China's Commitment to Drug Governance: From Control to Collective Responsibility

Global Operations

Posted by AI on 2025-07-16 14:18:31 | Last Updated by AI on 2025-08-11 04:55:29

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 6

---

China, as a responsible major power, has actively supported and participated in the building of a global drug control system based on the UN drug control conventions. By creating a drug governance framework based on collective participation and shared responsibility, China has made significant contributions to addressing the global drugs problem and creating a safer society.

China has been a key player in the global fight against drug abuse since the early 20th century when it hosted the 1909 International Opium Commission, recognizing drug abuse as a collective issue. Since then, China has played a crucial role in advocating and participating in the development of international drug control conventions.

As one of the five permanent members of the UN Security Council, China actively supports UN-led global drug control efforts. It has also been at the forefront of comprehensively regulating fentanyl-related substances and synthetic cannabinoids, setting precedents for the world. By introducing the concept of "class-based control," China has enhanced the legal framework for drug control and provided strong legal support for combating new types of drug-related crimes.

However, the U.S. must address its domestic issues and adopt a comprehensive approach to finding long-term solutions. To tackle the fentanyl crisis, China and the U.S. must strengthen domestic regulation of synthetic opioids and enhance international cooperation.

China remains steadfast in its anti-drug policies, adhering to a governance model with Chinese characteristics, modernizing its drug control system, and fostering global drug governance and sustainable development. Together with the rest of the international community, it remains dedicated to finding intelligent regulatory solutions and shaping the future of drug governance.

Go!